Εισάγετε μια λέξη ή φράση σε οποιαδήποτε γλώσσα 👆
Γλώσσα:
Μετάφραση και ανάλυση λέξεων από την τεχνητή νοημοσύνη ChatGPT
Σε αυτήν τη σελίδα μπορείτε να λάβετε μια λεπτομερή ανάλυση μιας λέξης ή μιας φράσης, η οποία δημιουργήθηκε χρησιμοποιώντας το ChatGPT, την καλύτερη τεχνολογία τεχνητής νοημοσύνης μέχρι σήμερα:
- πώς χρησιμοποιείται η λέξη
- συχνότητα χρήσης
- χρησιμοποιείται πιο συχνά στον προφορικό ή γραπτό λόγο
- επιλογές μετάφρασης λέξεων
- παραδείγματα χρήσης (πολλές φράσεις με μετάφραση)
- ετυμολογία
Τι (ποιος) είναι GABA reuptake inhibitor - ορισμός
GABA reuptake inhibitor
![gamma-Aminobutyric Acid]] (GABA)](https://commons.wikimedia.org/wiki/Special:FilePath/Gamma-Aminobuttersäure - gamma-aminobutyric acid.svg?width=200 "gamma-Aminobutyric Acid]] (GABA)")
DRUG CLASS
GABA reuptake inhibitors
A GABA reuptake inhibitor (GRI) is a type of drug which acts as a reuptake inhibitor for the neurotransmitter gamma-Aminobutyric acid (GABA) by blocking the action of the gamma-Aminobutyric acid transporters (GATs). This in turn leads to increased extracellular concentrations of GABA and therefore an increase in GABAergic neurotransmission.
Dopamine reuptake inhibitor
![[[Dopamine]] transporter inhibitors}}](https://commons.wikimedia.org/wiki/Special:FilePath/Neurotransmitter transporters inhibitors.png?width=200 "[[Dopamine]] transporter inhibitors}}")
CLASS OF DRUG
Dopamine reuptake inhibitors; Dopamine uptake inhibitors; Dopamine uptake inhibitor; DARI; Dopamine reuptake inhibition
A dopamine reuptake inhibitor (DRI) is a class of drug which acts as a reuptake inhibitor of the monoamine neurotransmitter dopamine by blocking the action of the dopamine transporter (DAT). Reuptake inhibition is achieved when extracellular dopamine not absorbed by the postsynaptic neuron is blocked from re-entering the presynaptic neuron.
Serotonin–norepinephrine reuptake inhibitor
CLASS OF ANTIDEPRESSANT DRUGS USED IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
SNRI; Ssnri; SSNRI; SNRIs; Serotonin-Norepinephrine Reuptake Inhibitor; Serotonin-norepinephrine Reuptake Inhibitor; Noradrenergic and selective serotonergic antidepressant; Norepinephrine/serotonin reuptake inhibitor; Serotonin-norepinephrine reuptake inhibitor; Serotonin–norepinephrine reuptake inhibitors; Serotonin-norepinephrine reuptake inhibitors; LY 2216684; Discovery and development of dual serotonin and norepinephrine reuptake inhibitors; User:Yrsukrutt/Discovery and development of dual serotonin and norepinephrine reuptake inhibitors; Serotonin norepinephrine reuptake inhibitors; Serotonin norepinephrine reuptake inhibitor; Serotonin-noradrenaline reuptake inhibitors; Serotonin–noradrenaline reuptake inhibitor; Serotonin-noradrenaline reuptake inhibitor
Serotonin–norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant drugs used to treat major depressive disorder (MDD), anxiety disorders, obsessive–compulsive disorder (OCD), social phobia, attention-deficit hyperactivity disorder (ADHD), chronic neuropathic pain, fibromyalgia syndrome (FMS), and menopausal symptoms. SNRIs are monoamine reuptake inhibitors; specifically, they inhibit the reuptake of serotonin and norepinephrine.
